Biomarker Design Forschung GmbH (BDF) is a biotech R&D company incorporated in April 2009. The staff includes all the employees of the research department of Biomedica Medizinprodukte GmbH & Co Kg (Biomedica), who have successfully developed new innovative ELISA systems for clinical research on diseases of the cardiovascular system and bone metabolism.

We focus our work on finding new innovative biomarkers by cooperation with basic research at Universities or with small and medium Biotech companies and our own internal research efforts.
The business concept of BDF is based on the above mentioned successful research activities, the scientific and commercial network established and includes selling of diagnostic concepts to commercial entities along with IP generated in the course of the research. Those concepts then will be turned into new diagnostic tools by those entities refunding BDF.

The staff of BDF has long term experience in developing ELISA technology. Several diagnostic assays have been developed and are presently sold worldwide by Biomedica (see www.bmgrp.com). Core know how of BDF includes antibody preparation, purification and labeling, stabilization of biological compounds, formulation and validation of components for diagnostic use under ISO 9001:2008 and GMP/GLP specifications.

Biomarker Design Forschungs GmbH

Providing new innovative tools for cutting edge clinical research